Trials / Terminated
TerminatedNCT02104414
Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy
Comparison of Rectal Infiltration of Exparel vs. 0.25% Bupivacaine With Epinephrine vs. Placebo for Analgesic Benefit Following Hemorrhoidectomy
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- St. Luke's-Roosevelt Hospital Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the quality and duration of pain relief after a hemorrhoidectomy, provided by locally administered liposomal bupivacaine versus bupivacaine hcl or control with saline. It is hypothesized that liposomal bupivacaine will provide more effective postoperative pain relief than both bupivacaine hcl and the control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exparel | 266 mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL) |
| DRUG | Bupivacaine HCl with Epinephrine | 75mg/30mL 0.25% Bupivacaine HCl with epinephrine |
| DRUG | Normal Saline | 30mL Normal Saline |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-04-04
- Last updated
- 2018-12-04
- Results posted
- 2018-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02104414. Inclusion in this directory is not an endorsement.